Skip to content

Study of intranasal oil instillation (Pratimarsha Nasya)for protective effect in healthy individuals

A pilot study to assess the effect of intranasal oil instillation (Pratimarsha Nasya)on nasal barrier function among healthy individuals - NaSH study

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/06/043096
Enrollment
90
Registered
2022-06-08
Start date
Unknown
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Central Council for Research in Ayurvedic Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Apparently healthy adults [as determined by clinical history, general physical examination, Hematological and biochemical parameters (CBC, LFT, RFT)], 2. Aged from 18 to 40 years age of any sex

Exclusion criteria

Exclusion criteria: b. Exclusion Criteria: i. Nasal conditions: Septal deviations, hypertrophied turbinates, intra nasal masses, symptoms as nasal bleeding, chronic rhinitis ii. Psychiatric or other conditions that in the opinion of the investigator may hamper study participation iii. Known cases of uncontrolled diabetes mellitus, uncontrolled hypertension iv. Pregnant or lactating women v. Regularly practicing Jalneti, Pranayam, or any other intranasal treatment since one month from the day of screening vi. On oral or intranasal steroid therapy since last 4 weeks

Design outcomes

Secondary

MeasureTime frame
1) Change in pH of nasal mucosa 2) Change in levels of cytokines viz., IL6, IL10, TNF α, IFN λ and Secretary Immunoglobin (sIgA) in nasal mucus 3) Change in mRNA expression of the tight junction proteins viz., Occludin, Claudins and JAM in nasal mucus. 4) Change in microbial diversity in the nasal mucosa 5) Incidence and severity of upper respiratory symptoms 6) Change in quality of sleep 7) Change in level of mental stress 8) ADRs and AEs Timepoint: Baseline, Weeks 4, 8, 12 and 16

Primary

MeasureTime frame
Change in expression of mucins viz., MUC5AC and MUC5B after intranasal oil instillationTimepoint: Baseline , Week 4, week 8, week 12, week 16

Countries

India

Contacts

Public ContactDr Sarika Chaturvedi

Dr D Y Patil VIdyapeeth

sarika.chaturvedi@dpu.edu.in02027805000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026